Cerebellar-Prefrontal Network Connectivity and Negative Symptoms in Schizophrenia
نویسندگان
چکیده
منابع مشابه
Prefrontal cortex, negative symptoms, and schizophrenia: an MRI study.
The present study measured prefrontal cortical gray and white matter volume in chronic, male schizophrenic subjects who were characterized by a higher proportion of mixed or negative symptoms than previous patients that we have evaluated. Seventeen chronic male schizophrenic subjects and 17 male control subjects were matched on age and handedness. Regions of interest (ROI) were measured using h...
متن کاملCerebellar-thalamic connectivity in schizophrenia.
The literature on alterations in brain structure and function in schizophrenia, particularly in relationship to impairments in cognitive, motor, and affective functions, has made it increasingly clear that changes in the function of a single brain region cannot explain the range of impairments seen in this illness.1–4 This realization has led to a surgence of interest in studies examining neuro...
متن کاملThe Effects of Bupropion on Negative Symptoms in Schizophrenia
Abstract:Purpose:This study was designed determine the efficacy of bupropion versus placebo in subjects with negative symptoms of schizophrenia.Methods:A convenience sample of 40 patients of both genders aged 18-60 years who were living in psychiatric care centers were randomly treated with bupropion (started with 75 mg twice a day; increased to 100 mg thrice daily) or placebo. The diagnosis of...
متن کاملNegative Symptoms and Negative Schizophrenia
This study determines the frequency distribution of prominent negative symptoms in a group of chronic, hospitalised schizophrenics. Thirty chronic Schizophrenic (D.S.M. III) patients were rated on the scale for Assessment of Negative Symptoms (SANS) and the prominent negative symptoms were correlated with age, sex and certain illness variables. Majority (80%) of patients had some or the other n...
متن کاملThe Effects of Bupropion on Negative Symptoms in Schizophrenia
Abstract:Purpose:This study was designed determine the efficacy of bupropion versus placebo in subjects with negative symptoms of schizophrenia.Methods:A convenience sample of 40 patients of both genders aged 18-60 years who were living in psychiatric care centers were randomly treated with bupropion (started with 75 mg twice a day; increased to 100 mg thrice daily) or placebo. The diagnosis of...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: American Journal of Psychiatry
سال: 2019
ISSN: 0002-953X,1535-7228
DOI: 10.1176/appi.ajp.2018.18040429